D Ribatti1, M G Ennas, A Vacca, F Ferreli, B Nico, S Orru, P Sirigu. 1. Department of Human Anatomy and Histology, University of Bari Medical School, Piazza G. Cesare, 11, Policlinico, 70124 Bari, Italy. ribatti@anatomia.uniba.it
Abstract
BACKGROUND: The importance of angiogenesis in melanoma has been controversial and is not homogeneous. Mast cell density (MCD) is highly correlated with the extent of both normal and pathological angiogenesis, such as that in chronic inflammatory diseases and tumours. METHODS: We evaluated the prognostic significance of tumour microvascular density (MVD) and MCD in 25 advanced melanoma patients after resection and a 4-5-year follow up: 48% of the patients were alive and free of metastases (good prognostic subgroup); 16% had developed regional nodal metastases (intermediate prognostic subgroup); and 36% had died (poor prognostic subgroup). Tissues samples were investigated immunohistochemically to count microvessels and mast cells with an antifactor VIII and an antitryptase antibody, respectively. RESULTS: Immunohistological staining showed a higher number of microvessels and mast cells in melanoma lesions of poor prognosis as compared with intermediate prognosis and with good prognosis, respectively. CONCLUSIONS: These data agree with those showing a close relationship between MCD and angiogenesis during tumour progression and demonstrate, for the first time, a prognostic significance of MCD in human melanoma.
BACKGROUND: The importance of angiogenesis in melanoma has been controversial and is not homogeneous. Mast cell density (MCD) is highly correlated with the extent of both normal and pathological angiogenesis, such as that in chronic inflammatory diseases and tumours. METHODS: We evaluated the prognostic significance of tumour microvascular density (MVD) and MCD in 25 advanced melanomapatients after resection and a 4-5-year follow up: 48% of the patients were alive and free of metastases (good prognostic subgroup); 16% had developed regional nodal metastases (intermediate prognostic subgroup); and 36% had died (poor prognostic subgroup). Tissues samples were investigated immunohistochemically to count microvessels and mast cells with an antifactor VIII and an antitryptase antibody, respectively. RESULTS: Immunohistological staining showed a higher number of microvessels and mast cells in melanoma lesions of poor prognosis as compared with intermediate prognosis and with good prognosis, respectively. CONCLUSIONS: These data agree with those showing a close relationship between MCD and angiogenesis during tumour progression and demonstrate, for the first time, a prognostic significance of MCD in humanmelanoma.
Authors: Matthew J Strouch; Eric C Cheon; Mohammad R Salabat; Seth B Krantz; Elias Gounaris; Laleh G Melstrom; Surabhi Dangi-Garimella; Edward Wang; Hidayatullah G Munshi; Khashayarsha Khazaie; David J Bentrem Journal: Clin Cancer Res Date: 2010-04-06 Impact factor: 12.531
Authors: Marius Raica; Anca Maria Cimpean; Beatrice Nico; Diego Guidolin; Domenico Ribatti Journal: Int J Exp Pathol Date: 2009-12-04 Impact factor: 1.925
Authors: Ge Jin; Hameem I Kawsar; Stanley A Hirsch; Chun Zeng; Xun Jia; Zhimin Feng; Santosh K Ghosh; Qing Yin Zheng; Aimin Zhou; Thomas M McIntyre; Aaron Weinberg Journal: PLoS One Date: 2010-06-08 Impact factor: 3.240
Authors: Dietmar M W Zaiss; Jorg van Loosdregt; Andrea Gorlani; Cornelis P J Bekker; Andrea Gröne; Maria Sibilia; Paul M P van Bergen en Henegouwen; Rob C Roovers; Paul J Coffer; Alice J A M Sijts Journal: Immunity Date: 2013-01-17 Impact factor: 31.745
Authors: Akhilesh K Sista; Robert J Knebel; Sidhartha Tavri; Magnus Johansson; David G DeNardo; Sophie E Boddington; Sirish A Kishore; Celina Ansari; Verena Reinhart; Fergus V Coakley; Lisa M Coussens; Heike E Daldrup-Link Journal: J Transl Med Date: 2009-11-11 Impact factor: 5.531